- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05811390
Non-surgical Treatment of Periimplantitis - Conventional Hand Instrumentation Versus Air-polishing
April 2, 2025 updated by: Universidade do Porto
Non-surgical Treatment of Periimplantitis - Conventional Hand Instrumentation Versus Air-polishing and Systemic Metronidazole With a 12 Months Follow-up, a Parallel Randomized Controlled Clinical Trial
The purpose of this study is to evaluate the clinical efficacy of ultrasonic instrumentation versus the use of an erythritol jet in the treatment of peri-implantitis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
To carry out this study, the investigators considered a treatment protocol for periimplantitis consisting of 2 phases.
The first phase corresponds to the non-surgical treatment of periimplantitis, which can be performed using various techniques.
In the present study, it will be carried out using manual instrumentation (with ultrasound and curettes) or with an erythritol jet.
In both cases, systemic antibiotic therapy with metronidazole will be performed.
The results obtained during the follow-ups will allow the evaluation of the effectiveness of the treatment carried out.
If this does not prove to be successful, through an evaluation of clinical and radiographic criteria, patients will be advised to undergo a second phase of treatment, in this case a surgical treatment of peri-implantitis, but which will no longer be part of the interventions carried out and documented in this study.
Patients for whom the unsatisfactory treatment was considered effective will be allocated to a periimplant support treatment program, which means that they will be advised to carry out maintenance consultations at the FMDUP clinic with a specific and individualized periodicity in order to maintain the health of the periimplant tissues and the remaining oral cavity.
The study will be carried out by the students of the Specialization in Periodontology and Oral Implantology 2021-2024 of the Faculty of Dental Medicine of the University of Porto (FMDUP).
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
OPorto, Portugal, 4200-393
- Faculty of Dentistry at the University of OPorto
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- At least 1 osseointegrated implant diagnosed with peri-implantitis (according to the new Classification of Periodontal and Peri-implant Diseases and Conditions) and rehabilitated with screw-retained crown
- Patients of legal age (≥18 years old)
Exclusion Criteria:
- Uncontrolled systemic pathologies, namely diabetes mellitus (HbA1c > 7% or >53 mmol/mol)
- Pregnant or lactating patients
- Severe smoking (>20 cigarettes/day)
- Systemic pathologies, medication or treatments that cause alterations in bone metabolism (for example: osteoporosis, bisphosphonates, radiotherapy of the head and neck)
- Patients who missed study control visits
- Patients who have received systemic antibiotic therapy in the last 2 months
- Patients with allergies to any of the components used in the study, namely to erythritol
- Implants that have previously undergone surgical treatment for peri-implantitis
- Implants with bone loss greater than 2/3 of their length and/or mobility
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: erythritol jet (EMS)
An erythritol jet (Perioflow from EMS) will be used to debride the periodontal pockets of oral implants diagnosed with per-implantitis.
|
Use of an erythritol jet in the non-surgical treatment of periimplantitis together with systemic metronidazole
|
|
Active Comparator: Manual instrumentation
An ultrasonic handpiece will be used to debride the periodontal pockets of oral implants diagnosed with per-implantitis.
|
Use of manual instrumentation in the non-surgical treatment of periimplantitis together with systemic metronidazole
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in probing pocket depth
Time Frame: 0, 3, 6, 12 months
|
The distance measured from the base of the sulcus or pocket to the free gingival margin at six points per implant (measured in millimetres).
|
0, 3, 6, 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PROMS
Time Frame: 0 months
|
Patient reported outcomes reported on a visual analog scale from 0 (no pain) to 10 (maximum pain).
|
0 months
|
|
Change in alveolar bone level
Time Frame: 0,12 months
|
Radiographically measured alveolar bone level from the alveolar crest to the implant's neck, mesially and distally (measured in millimetres).
|
0,12 months
|
|
Change in gingival recession
Time Frame: 0, 3, 6, 12 months
|
Gingival recession measured at six points per implant with a periodontal probe, from the cementum-enamel junction to the bottom of the probable pocket (measured in millimetres).
|
0, 3, 6, 12 months
|
|
Bleeding on probing
Time Frame: 0, 3, 6, 12 months
|
Bleeding on probing (in percentage) assessed 30 seconds after probing, through a dichotomous scoring system used at six sites per implant using one (1) and zero (0) for presence or absence, respectively.
|
0, 3, 6, 12 months
|
|
Implant survival rate
Time Frame: 0, 12 months
|
Percentage of implants that survived after 1 year follow-up (implants that remain in the patient's mouth after 1 year).
|
0, 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Ana Isabel Moreira, Faculdade De Medicina Dentaria da Universidade do Porto
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2022
Primary Completion (Actual)
June 30, 2024
Study Completion (Actual)
July 30, 2024
Study Registration Dates
First Submitted
February 23, 2023
First Submitted That Met QC Criteria
April 12, 2023
First Posted (Actual)
April 13, 2023
Study Record Updates
Last Update Posted (Actual)
April 6, 2025
Last Update Submitted That Met QC Criteria
April 2, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Periimplantitis treatment
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.